In recent news, Meftal, a painkiller medication, gained attention following a drug safety alert issued by the IPC, indicating a potential association with DRESS syndrome. Despite this alert, physicians have reassured the public of Meftal's safety. They emphasized that while adverse effects are known, they are rare. Additionally, they cautioned against the indiscriminate use of the drug without a prescription. Join us in this session with Dr. Sanjay Kalra and Dr. Ketan Mehta on December 30 at 7:00 p.m. to learn more about the critical role of drug safety alerts in maintaining the integrity of medical practices and patient well-being.